{"h1":"Series A biotech investors","sub":"27 investors with a publicly documented Series A biotech deal announced in the last 6 months, each carrying a SeedForge-recorded claim and a link to the underlying announcement. Stale evidence ages out at the weekly refresh.","kind":"list","rows":[{"name":"ARCH Venture Partners","role":"lead","slug":"arch-venture-partners","type":"VC_FUND","claim":"SeedForge records ARCH Venture Partners as a participant in Ramona's financing, announced 2026-09-22.","deal_id":"arch-venture-partners--2026-09-22--ramona","dated_on":"2026-09-22","publicId":"zy42f9","deal_line":"Backed Ramona · announced Sep 22, 2026","fund_page":"/investors/funds/arch-venture-partners--zy42f9","check_size":"from $50K","round_band":"~$25M","type_label":"VC fund","ages_out_on":"2027-03-21","investor_id":"arch-venture-partners","website_url":null,"announced_on":"2026-09-22","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/ramona-optics_were-thrilled-to-announce-that-ramona-has-activity-7508150209848414208-3hXp","stages_label":"Series A","check_max_usd":null,"check_min_usd":50000,"evidence_path":"/investors/funds/arch-venture-partners--zy42f9/evidence/2026-09-22--ramona","closing_source":null,"evidence_quote":"Ramona has raised $25 million in an oversubscribed Series A financing round, led by ARCH Venture Partners","funded_company":"Ramona","has_intro_path":false,"verified_month":"Sep 2026","geography_label":"N. America","mandate_geography_label":"Europe · N. America"},{"name":"SV Angel","role":"participant","slug":"sv-angel","type":"VC_FUND","claim":"SeedForge records SV Angel as a participant in Huskeys's financing, announced 2026-09-08.","deal_id":"sv-angel--2026-09-08--huskeys","dated_on":"2026-09-08","publicId":"s23c60","deal_line":"Backed Huskeys · announced Sep 8, 2026","fund_page":"/investors/funds/sv-angel--s23c60","check_size":null,"round_band":"$6M–$27M","type_label":"VC fund","ages_out_on":"2027-03-07","investor_id":"sv-angel","website_url":"https://svangel.com/","announced_on":"2026-09-08","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/technadu_huskeys-cybersecurity-networksecurity-activity-7503106331625607168-KOA9","stages_label":"Series A","check_max_usd":20000000,"check_min_usd":null,"evidence_path":"/investors/funds/sv-angel--s23c60/evidence/2026-09-08--huskeys","closing_source":null,"evidence_quote":"Additional Investors: Merlin Ventures, Skinos Ventures, Zscaler, Okta, SV Angel, 10D","funded_company":"Huskeys","has_intro_path":true,"verified_month":"Sep 2026","geography_label":"Europe","mandate_geography_label":"N. America"},{"name":"Oak HC/FT","role":"lead","slug":"oak-hc-ft","type":"VC_FUND","claim":"SeedForge records Oak HC/FT as a participant in Dash Bio's financing, announced 2026-08-10.","deal_id":"oak-hc-ft--2026-08-10--dash-bio","dated_on":"2026-08-10","publicId":"gkk60p","deal_line":"Backed Dash Bio · announced Aug 10, 2026","fund_page":"/investors/funds/oak-hc-ft--gkk60p","check_size":null,"round_band":"~$30M","type_label":"VC fund","ages_out_on":"2027-02-06","investor_id":"oak-hc-ft","website_url":null,"announced_on":"2026-08-10","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/futuretechly369_drug-development-doesnt-slow-down-because-activity-7492640972070084608-m7gu","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/oak-hc-ft--gkk60p/evidence/2026-08-10--dash-bio","closing_source":null,"evidence_quote":"🧠 Dash Bio Waltham, MA-based Raises $30M Series A to Deliver GLP-Compliant Bioanalysis Infrastructure in Days 🔹 Lead Investor: Oak HC/FT 🔹 Participating: Freestyle Capital, Swift Ventures Leadership: – Dave Johnson, CEO & Co-Founder – Ander Tallett, COO & Co-Founder – Ely Porter, CSO & Co-Founder What They're Building: A GLP-compliant bioanalysis platform combining robotics, proprietary lab OS, & ","funded_company":"Dash Bio","has_intro_path":false,"verified_month":"Aug 2026","geography_label":"N. America","mandate_geography_label":"Europe · Middle East · N. America"},{"name":"Speciale Invest","role":"co-lead","slug":"speciale-invest","type":"VC_FUND","claim":"SeedForge records Speciale Invest as a participant in Peptris's financing, announced 2026-08-05.","deal_id":"speciale-invest--2026-08-05--peptris","dated_on":"2026-08-05","publicId":"47f9b6","deal_line":"Backed Peptris · announced Aug 5, 2026","fund_page":"/investors/funds/speciale-invest--47f9b6","check_size":"$100K to $500K","round_band":"$2M–$12M","type_label":"VC fund","ages_out_on":"2027-02-01","investor_id":"speciale-invest","website_url":"https://www.specialeinvest.com/","announced_on":"2026-08-05","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/gyaansetu-bharat_india-ai-artificialintelligence-activity-7490816844652539904-i3iF","stages_label":"Series A","check_max_usd":500000,"check_min_usd":100000,"evidence_path":"/investors/funds/speciale-invest--47f9b6/evidence/2026-08-05--peptris","closing_source":null,"evidence_quote":"the round co-led by IAN Alpha Fund and Speciale Invest","funded_company":"Peptris","has_intro_path":true,"verified_month":"Aug 2026","geography_label":"APAC","mandate_geography_label":"APAC · N. America"},{"name":"Freestyle Capital","role":"participant","slug":"freestyle-capital","type":"VC_FUND","claim":"SeedForge records Freestyle Capital as a participant in Dash Bio's financing, announced 2026-08-04. Evidence posted 2026-08-10.","deal_id":"freestyle-capital--2026-08-10--dash-bio","dated_on":"2026-08-04","publicId":"bsjpxb","deal_line":"Backed Dash Bio · announced Aug 4, 2026 · evidence posted Aug 10, 2026","fund_page":"/investors/funds/freestyle-capital--bsjpxb","check_size":"$1M to $4M","round_band":"~$30M","type_label":"VC fund","ages_out_on":"2027-01-31","investor_id":"freestyle-capital","website_url":null,"announced_on":"2026-08-10","closing_date":"2026-08-04","evidence_url":"https://www.linkedin.com/posts/futuretechly369_drug-development-doesnt-slow-down-because-activity-7492640972070084608-m7gu","stages_label":"Series A","check_max_usd":4000000,"check_min_usd":1000000,"evidence_path":"/investors/funds/freestyle-capital--bsjpxb/evidence/2026-08-10--dash-bio","closing_source":"researched","evidence_quote":"Participating: Freestyle Capital, Swift Ventures","funded_company":"Dash Bio","has_intro_path":false,"verified_month":"Aug 2026","geography_label":"N. America","mandate_geography_label":"APAC · Europe · Middle East · N. America"},{"name":"Swift Ventures","role":"participant","slug":"swift-ventures","type":"VC_FUND","claim":"SeedForge records Swift Ventures as a participant in Dash Bio's financing, announced 2026-08-03. Evidence posted 2026-08-10.","deal_id":"swift-ventures--2026-08-10--dash-bio","dated_on":"2026-08-03","publicId":"hnnvvs","deal_line":"Backed Dash Bio · announced Aug 3, 2026 · evidence posted Aug 10, 2026","fund_page":"/investors/funds/swift-ventures--hnnvvs","check_size":null,"round_band":"~$30M","type_label":"VC fund","ages_out_on":"2027-01-30","investor_id":"swift-ventures","website_url":null,"announced_on":"2026-08-10","closing_date":"2026-08-03","evidence_url":"https://www.linkedin.com/posts/futuretechly369_drug-development-doesnt-slow-down-because-activity-7492640972070084608-m7gu","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/swift-ventures--hnnvvs/evidence/2026-08-10--dash-bio","closing_source":"researched","evidence_quote":"Participating: Freestyle Capital, Swift Ventures","funded_company":"Dash Bio","has_intro_path":false,"verified_month":"Aug 2026","geography_label":"N. America","mandate_geography_label":null},{"name":"Gaorong Ventures","role":null,"slug":"gaorong-ventures","type":"VC_FUND","claim":"SeedForge records Gaorong Ventures as a participant in GenAns Biotech's financing, announced 2026-07-30.","deal_id":"gaorong-ventures--2026-07-30--genans-biotech","dated_on":"2026-07-30","publicId":"5s6kg7","deal_line":"Backed GenAns Biotech · announced Jul 30, 2026","fund_page":"/investors/funds/gaorong-ventures--5s6kg7","check_size":null,"round_band":"~$900M","type_label":"VC fund","ages_out_on":"2027-01-26","investor_id":"gaorong-ventures","website_url":null,"announced_on":"2026-07-30","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/co-win-ventures_we-are-excited-to-announce-that-our-activity-7488476244133650433-CaBd","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/gaorong-ventures--5s6kg7/evidence/2026-07-30--genans-biotech","closing_source":null,"evidence_quote":"new investors such as Gaorong Ventures","funded_company":"GenAns Biotech","has_intro_path":false,"verified_month":"Jul 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Mitsubishi UFJ Capital","role":null,"slug":"mitsubishi-ufj-capital","type":"VC_FUND","claim":"SeedForge records Mitsubishi UFJ Capital as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-29.","deal_id":"mitsubishi-ufj-capital--2026-07-29--core-biomedicine-inc","dated_on":"2026-07-29","publicId":"e5may6","deal_line":"Backed CORE Biomedicine, Inc. · announced Jul 29, 2026","fund_page":"/investors/funds/mitsubishi-ufj-capital--e5may6","check_size":null,"round_band":"~$21M","type_label":"VC fund","ages_out_on":"2027-01-25","investor_id":"mitsubishi-ufj-capital","website_url":null,"announced_on":"2026-07-29","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/healthufit_corebiomedicine-funding-startupnews-activity-7488190438789533698-Tp5N","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/mitsubishi-ufj-capital--e5may6/evidence/2026-07-29--core-biomedicine-inc","closing_source":null,"evidence_quote":"InnoPinnacle Fund, Mitsubishi UFJ Capital, Suzhou Capital Group","funded_company":"CORE Biomedicine, Inc.","has_intro_path":false,"verified_month":"Jul 2026","geography_label":null,"mandate_geography_label":null},{"name":"YuanBio Venture Capital","role":null,"slug":"yuanbio-venture-capital","type":"VC_FUND","claim":"SeedForge records YuanBio Venture Capital as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-29.","deal_id":"yuanbio-venture-capital--2026-07-29--core-biomedicine-inc","dated_on":"2026-07-29","publicId":"ma44d4","deal_line":"Backed CORE Biomedicine, Inc. · announced Jul 29, 2026","fund_page":"/investors/funds/yuanbio-venture-capital--ma44d4","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2027-01-25","investor_id":"yuanbio-venture-capital","website_url":null,"announced_on":"2026-07-29","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/healthufit_corebiomedicine-funding-startupnews-activity-7488190438789533698-Tp5N","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/yuanbio-venture-capital--ma44d4/evidence/2026-07-29--core-biomedicine-inc","closing_source":null,"evidence_quote":"and Elikon Venture, with participation from InnoPinnacle Fund, Mitsubishi UFJ Capital, Suzhou Capital Group Co., Ltd, CD Capital, YuanBio Venture Capital, Vision Incubate, and Root Venture Partners.","funded_company":"CORE Biomedicine, Inc.","has_intro_path":false,"verified_month":"Jul 2026","geography_label":null,"mandate_geography_label":null},{"name":"Vision Incubate","role":null,"slug":"vision-incubate","type":"VC_FUND","claim":"SeedForge records Vision Incubate as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29.","deal_id":"vision-incubate--2026-07-29--core-biomedicine-inc","dated_on":"2026-07-28","publicId":"a21evs","deal_line":"Backed CORE Biomedicine, Inc. · announced Jul 28, 2026 · evidence posted Jul 29, 2026","fund_page":"/investors/funds/vision-incubate--a21evs","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2027-01-24","investor_id":"vision-incubate","website_url":null,"announced_on":"2026-07-29","closing_date":"2026-07-28","evidence_url":"https://www.linkedin.com/posts/healthufit_corebiomedicine-funding-startupnews-activity-7488190438789533698-Tp5N","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/vision-incubate--a21evs/evidence/2026-07-29--core-biomedicine-inc","closing_source":"researched","evidence_quote":"and Elikon Venture, with participation from InnoPinnacle Fund, Mitsubishi UFJ Capital, Suzhou Capital Group Co., Ltd, CD Capital, YuanBio Venture Capital, Vision Incubate, and Root Venture Partners.","funded_company":"CORE Biomedicine, Inc.","has_intro_path":false,"verified_month":"Jul 2026","geography_label":null,"mandate_geography_label":null},{"name":"Elikon Venture","role":null,"slug":"elikon-venture","type":"VC_FUND","claim":"SeedForge records Elikon Venture as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29.","deal_id":"elikon-venture--2026-07-29--core-biomedicine-inc","dated_on":"2026-07-28","publicId":"wdtjhy","deal_line":"Backed CORE Biomedicine, Inc. · announced Jul 28, 2026 · evidence posted Jul 29, 2026","fund_page":"/investors/funds/elikon-venture--wdtjhy","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2027-01-24","investor_id":"elikon-venture","website_url":null,"announced_on":"2026-07-29","closing_date":"2026-07-28","evidence_url":"https://www.linkedin.com/posts/healthufit_corebiomedicine-funding-startupnews-activity-7488190438789533698-Tp5N","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/elikon-venture--wdtjhy/evidence/2026-07-29--core-biomedicine-inc","closing_source":"researched","evidence_quote":"The round was co-led by UTokyo Innovation Platform Co., Ltd. and Elikon Venture","funded_company":"CORE Biomedicine, Inc.","has_intro_path":false,"verified_month":"Jul 2026","geography_label":null,"mandate_geography_label":null},{"name":"UTokyo Innovation Platform Co., Ltd. (UTokyo IPC)","role":null,"slug":"utokyo-innovation-platform-co-ltd-utokyo-ipc","type":"VC_FUND","claim":"SeedForge records UTokyo Innovation Platform Co., Ltd. (UTokyo IPC) as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29.","deal_id":"utokyo-innovation-platform-co-ltd-utokyo-ipc--2026-07-29--core-biomedicine-inc","dated_on":"2026-07-28","publicId":"7wkhnc","deal_line":"Backed CORE Biomedicine, Inc. · announced Jul 28, 2026 · evidence posted Jul 29, 2026","fund_page":"/investors/funds/utokyo-innovation-platform-co-ltd-utokyo-ipc--7wkhnc","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2027-01-24","investor_id":"utokyo-innovation-platform-co-ltd-utokyo-ipc","website_url":null,"announced_on":"2026-07-29","closing_date":"2026-07-28","evidence_url":"https://www.linkedin.com/posts/healthufit_corebiomedicine-funding-startupnews-activity-7488190438789533698-Tp5N","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/utokyo-innovation-platform-co-ltd-utokyo-ipc--7wkhnc/evidence/2026-07-29--core-biomedicine-inc","closing_source":"researched","evidence_quote":"The round was co-led by UTokyo Innovation Platform Co., Ltd. and Elikon Venture","funded_company":"CORE Biomedicine, Inc.","has_intro_path":false,"verified_month":"Jul 2026","geography_label":null,"mandate_geography_label":null},{"name":"Founders Fund","role":null,"slug":"founders-fund","type":"VC_FUND","claim":"SeedForge records Founders Fund as a participant in Shinkei Systems's financing, announced 2026-07-27.","deal_id":"founders-fund--2026-07-27--shinkei-systems","dated_on":"2026-07-27","publicId":"phvyr0","deal_line":"Backed Shinkei Systems · announced Jul 27, 2026","fund_page":"/investors/funds/founders-fund--phvyr0","check_size":null,"round_band":"$4M–$50M","type_label":"VC fund","ages_out_on":"2027-01-23","investor_id":"founders-fund","website_url":null,"announced_on":"2026-07-27","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/united-nations-startups_robotics-ai-artificialintelligence-activity-7487471254489235456-8XDz","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/founders-fund--phvyr0/evidence/2026-07-27--shinkei-systems","closing_source":null,"evidence_quote":"The funding round was co-led by Founders Fund and Interlagos","funded_company":"Shinkei Systems","has_intro_path":false,"verified_month":"Jul 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Korea Omega Investment Corp.","role":"participant","slug":"korea-omega-investment-corp","type":"VC_FUND","claim":"SeedForge records Korea Omega Investment Corp. as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21.","deal_id":"korea-omega-investment-corp--2026-07-21--brenus-pharma","dated_on":"2026-07-20","publicId":"8ayt04","deal_line":"Backed Brenus Pharma · announced Jul 20, 2026 · evidence posted Jul 21, 2026","fund_page":"/investors/funds/korea-omega-investment-corp--8ayt04","check_size":null,"round_band":"~$13M","type_label":"VC fund","ages_out_on":"2027-01-16","investor_id":"korea-omega-investment-corp","website_url":null,"announced_on":"2026-07-21","closing_date":"2026-07-20","evidence_url":"https://www.linkedin.com/posts/byte51data_biotech-immunotherapy-oncology-activity-7485344947739713536-VM3-","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/korea-omega-investment-corp--8ayt04/evidence/2026-07-21--brenus-pharma","closing_source":"researched","evidence_quote":"The round included participation from Angelor, UI Investissement, Crédit Agricole, Noshaq, ORSA (ex Investsud), BIO JAG, Bpifrance, Sambrinvest, and Korea Omega Investment Corp..","funded_company":"Brenus Pharma","has_intro_path":false,"verified_month":"Jul 2026","geography_label":"Europe","mandate_geography_label":null},{"name":"Sambrinvest","role":"participant","slug":"sambrinvest","type":"VC_FUND","claim":"SeedForge records Sambrinvest as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21.","deal_id":"sambrinvest--2026-07-21--brenus-pharma","dated_on":"2026-07-20","publicId":"vkx806","deal_line":"Backed Brenus Pharma · announced Jul 20, 2026 · evidence posted Jul 21, 2026","fund_page":"/investors/funds/sambrinvest--vkx806","check_size":null,"round_band":"~$13M","type_label":"VC fund","ages_out_on":"2027-01-16","investor_id":"sambrinvest","website_url":null,"announced_on":"2026-07-21","closing_date":"2026-07-20","evidence_url":"https://www.linkedin.com/posts/byte51data_biotech-immunotherapy-oncology-activity-7485344947739713536-VM3-","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/sambrinvest--vkx806/evidence/2026-07-21--brenus-pharma","closing_source":"researched","evidence_quote":"The round included participation from Angelor, UI Investissement, Crédit Agricole, Noshaq, ORSA (ex Investsud), BIO JAG, Bpifrance, Sambrinvest, and Korea Omega Investment Corp..","funded_company":"Brenus Pharma","has_intro_path":false,"verified_month":"Jul 2026","geography_label":"Europe","mandate_geography_label":"Europe"},{"name":"Noshaq","role":"participant","slug":"noshaq","type":"VC_FUND","claim":"SeedForge records Noshaq as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21.","deal_id":"noshaq--2026-07-21--brenus-pharma","dated_on":"2026-07-20","publicId":"8yj33d","deal_line":"Backed Brenus Pharma · announced Jul 20, 2026 · evidence posted Jul 21, 2026","fund_page":"/investors/funds/noshaq--8yj33d","check_size":"$100K to $5M","round_band":"~$13M","type_label":"VC fund","ages_out_on":"2027-01-16","investor_id":"noshaq","website_url":"https://www.noshaq.be/","announced_on":"2026-07-21","closing_date":"2026-07-20","evidence_url":"https://www.linkedin.com/posts/byte51data_biotech-immunotherapy-oncology-activity-7485344947739713536-VM3-","stages_label":"Series A","check_max_usd":5000000,"check_min_usd":100000,"evidence_path":"/investors/funds/noshaq--8yj33d/evidence/2026-07-21--brenus-pharma","closing_source":"researched","evidence_quote":"The round included participation from Angelor, UI Investissement, Crédit Agricole, Noshaq, ORSA (ex Investsud), BIO JAG, Bpifrance, Sambrinvest, and Korea Omega Investment Corp..","funded_company":"Brenus Pharma","has_intro_path":false,"verified_month":"Jul 2026","geography_label":"Europe","mandate_geography_label":"Europe"},{"name":"Pangaea Ventures","role":null,"slug":"pangaea-ventures","type":"VC_FUND","claim":"SeedForge records Pangaea Ventures as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16.","deal_id":"pangaea-ventures--2026-06-16--dioseve","dated_on":"2026-06-17","publicId":"a9khzm","deal_line":"Backed Dioseve · announced Jun 17, 2026 · evidence posted Jun 16, 2026","fund_page":"/investors/funds/pangaea-ventures--a9khzm","check_size":"$3M to $8M","round_band":"~$7M","type_label":"VC fund","ages_out_on":"2026-12-14","investor_id":"pangaea-ventures","website_url":null,"announced_on":"2026-06-16","closing_date":"2026-06-17","evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":8000000,"check_min_usd":3000000,"evidence_path":"/investors/funds/pangaea-ventures--a9khzm/evidence/2026-06-16--dioseve","closing_source":"researched","evidence_quote":"New investors D4V, Shionogi & Co., Ltd., and Pangaea Ventures also joined the round.","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":"Europe · N. America"},{"name":"Shionogi & Co., Ltd.","role":null,"slug":"shionogi-co-ltd","type":"VC_FUND","claim":"SeedForge records Shionogi & Co., Ltd. as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16.","deal_id":"shionogi-co-ltd--2026-06-16--dioseve","dated_on":"2026-06-17","publicId":"tr1cfq","deal_line":"Backed Dioseve · announced Jun 17, 2026 · evidence posted Jun 16, 2026","fund_page":"/investors/funds/shionogi-co-ltd--tr1cfq","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-12-14","investor_id":"shionogi-co-ltd","website_url":null,"announced_on":"2026-06-16","closing_date":"2026-06-17","evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/shionogi-co-ltd--tr1cfq/evidence/2026-06-16--dioseve","closing_source":"researched","evidence_quote":"New investors D4V, Shionogi & Co., Ltd., and Pangaea Ventures also joined the round.","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"DG Daiwa Ventures","role":null,"slug":"dg-daiwa-ventures","type":"VC_FUND","claim":"SeedForge records DG Daiwa Ventures as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16.","deal_id":"dg-daiwa-ventures--2026-06-16--dioseve","dated_on":"2026-06-17","publicId":"md5sqy","deal_line":"Backed Dioseve · announced Jun 17, 2026 · evidence posted Jun 16, 2026","fund_page":"/investors/funds/dg-daiwa-ventures--md5sqy","check_size":null,"round_band":"~$7M","type_label":"VC fund","ages_out_on":"2026-12-14","investor_id":"dg-daiwa-ventures","website_url":"https://dg-daiwa-v.com/en/","announced_on":"2026-06-16","closing_date":"2026-06-17","evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/dg-daiwa-ventures--md5sqy/evidence/2026-06-16--dioseve","closing_source":"researched","evidence_quote":"Archetype Ventures served as lead investor, with continued participation from DG Daiwa Ventures and Mirai Door (Asuka Innovation Fund).","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":"APAC · Europe · N. America"},{"name":"D4V","role":null,"slug":"d4v","type":"VC_FUND","claim":"SeedForge records D4V as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16.","deal_id":"d4v--2026-06-16--dioseve","dated_on":"2026-06-17","publicId":"bex5zm","deal_line":"Backed Dioseve · announced Jun 17, 2026 · evidence posted Jun 16, 2026","fund_page":"/investors/funds/d4v--bex5zm","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-12-14","investor_id":"d4v","website_url":null,"announced_on":"2026-06-16","closing_date":"2026-06-17","evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/d4v--bex5zm/evidence/2026-06-16--dioseve","closing_source":"researched","evidence_quote":"New investors D4V, Shionogi & Co., Ltd., and Pangaea Ventures also joined the round.","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Mirai Door","role":null,"slug":"mirai-door","type":"VC_FUND","claim":"SeedForge records Mirai Door as a participant in Dioseve's financing, announced 2026-06-16.","deal_id":"mirai-door--2026-06-16--dioseve","dated_on":"2026-06-16","publicId":"d1km6j","deal_line":"Backed Dioseve · announced Jun 16, 2026","fund_page":"/investors/funds/mirai-door--d1km6j","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-12-13","investor_id":"mirai-door","website_url":null,"announced_on":"2026-06-16","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/mirai-door--d1km6j/evidence/2026-06-16--dioseve","closing_source":null,"evidence_quote":"Archetype Ventures served as lead investor, with continued participation from DG Daiwa Ventures and Mirai Door (Asuka Innovation Fund).","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Archetype Ventures","role":null,"slug":"archetype-ventures","type":"VC_FUND","claim":"SeedForge records Archetype Ventures as a participant in Dioseve's financing, announced 2026-06-16.","deal_id":"archetype-ventures--2026-06-16--dioseve","dated_on":"2026-06-16","publicId":"f3dqa1","deal_line":"Backed Dioseve · announced Jun 16, 2026","fund_page":"/investors/funds/archetype-ventures--f3dqa1","check_size":null,"round_band":"~$7M","type_label":"VC fund","ages_out_on":"2026-12-13","investor_id":"archetype-ventures","website_url":null,"announced_on":"2026-06-16","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/hk-business-wire_dioseve-secures-jpy-145-billion-to-advance-activity-7472685204478840832-KkqA","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/archetype-ventures--f3dqa1/evidence/2026-06-16--dioseve","closing_source":null,"evidence_quote":"Archetype Ventures served as lead investor, with continued participation from DG Daiwa Ventures and Mirai Door (Asuka Innovation Fund).","funded_company":"Dioseve","has_intro_path":false,"verified_month":"Jun 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Good Startup","role":null,"slug":"good-startup","type":"VC_FUND","claim":"SeedForge records Good Startup as a participant in StrainX Bioworks's financing, announced 2026-05-25.","deal_id":"good-startup--2026-05-25--strainx-bioworks","dated_on":"2026-05-25","publicId":"msbkgp","deal_line":"Backed StrainX Bioworks · announced May 25, 2026","fund_page":"/investors/funds/good-startup--msbkgp","check_size":null,"round_band":"~$13M","type_label":"VC fund","ages_out_on":"2026-11-21","investor_id":"good-startup","website_url":null,"announced_on":"2026-05-25","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/equity360_equity360-startupfunding-syntheticbiology-activity-7464564404861251587-sof0","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/good-startup--msbkgp/evidence/2026-05-25--strainx-bioworks","closing_source":null,"evidence_quote":"Participation from: Good Startup, Sparrow Capital, Sun Icon Ventures, Dhoka Ventures, and WTF (India) Delhi Angels","funded_company":"StrainX Bioworks","has_intro_path":false,"verified_month":"May 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Fortune Capital","role":null,"slug":"fortune-capital","type":"VC_FUND","claim":"SeedForge records Fortune Capital as a participant in Degron Therapeutics's financing, announced 2026-05-14. Evidence posted 2026-05-21.","deal_id":"fortune-capital--2026-05-21--degron-therapeutics","dated_on":"2026-05-14","publicId":"s0w6h2","deal_line":"Backed Degron Therapeutics · announced May 14, 2026 · evidence posted May 21, 2026","fund_page":"/investors/funds/fortune-capital--s0w6h2","check_size":null,"round_band":"~$40M","type_label":"VC fund","ages_out_on":"2026-11-10","investor_id":"fortune-capital","website_url":null,"announced_on":"2026-05-21","closing_date":"2026-05-14","evidence_url":"https://www.linkedin.com/posts/degrontx_degron-therapeutics-closes-40-million-series-activity-7463059491253604352-Zygh","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/fortune-capital--s0w6h2/evidence/2026-05-21--degron-therapeutics","closing_source":"researched","evidence_quote":"Additional investors include GTJA Investment Group, Fortune Capital, CSPC & Growth, ApicHope","funded_company":"Degron Therapeutics","has_intro_path":false,"verified_month":"May 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"GAGE Capital","role":null,"slug":"gage-capital","type":"VC_FUND","claim":"SeedForge records GAGE Capital as a participant in Degron Therapeutics's financing, announced 2026-05-14.","deal_id":"gage-capital--2026-05-14--degron-therapeutics","dated_on":"2026-05-14","publicId":"mfhc9f","deal_line":"Backed Degron Therapeutics · announced May 14, 2026","fund_page":"/investors/funds/gage-capital--mfhc9f","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-11-10","investor_id":"gage-capital","website_url":null,"announced_on":"2026-05-14","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/pulse2news_degron-therapeutics-40-million-series-a-activity-7460693968167739393-FF6v","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/gage-capital--mfhc9f/evidence/2026-05-14--degron-therapeutics","closing_source":null,"evidence_quote":"Kinghall Ventures, and GAGE Capital","funded_company":"Degron Therapeutics","has_intro_path":false,"verified_month":"May 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"GTJA Investment Group","role":null,"slug":"gtja-investment-group","type":"VC_FUND","claim":"SeedForge records GTJA Investment Group as a participant in Degron Therapeutics's financing, announced 2026-05-14.","deal_id":"gtja-investment-group--2026-05-14--degron-therapeutics","dated_on":"2026-05-14","publicId":"4trxfy","deal_line":"Backed Degron Therapeutics · announced May 14, 2026","fund_page":"/investors/funds/gtja-investment-group--4trxfy","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-11-10","investor_id":"gtja-investment-group","website_url":null,"announced_on":"2026-05-14","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/pulse2news_degron-therapeutics-40-million-series-a-activity-7460693968167739393-FF6v","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/gtja-investment-group--4trxfy/evidence/2026-05-14--degron-therapeutics","closing_source":null,"evidence_quote":"with participation from GTJA Investment Group, Fortune Capital, CSPC & Growth","funded_company":"Degron Therapeutics","has_intro_path":false,"verified_month":"May 2026","geography_label":"APAC","mandate_geography_label":null},{"name":"Kinghall Ventures","role":null,"slug":"kinghall-ventures","type":"VC_FUND","claim":"SeedForge records Kinghall Ventures as a participant in Degron Therapeutics's financing, announced 2026-05-14.","deal_id":"kinghall-ventures--2026-05-14--degron-therapeutics","dated_on":"2026-05-14","publicId":"hj35w8","deal_line":"Backed Degron Therapeutics · announced May 14, 2026","fund_page":"/investors/funds/kinghall-ventures--hj35w8","check_size":null,"round_band":null,"type_label":"VC fund","ages_out_on":"2026-11-10","investor_id":"kinghall-ventures","website_url":null,"announced_on":"2026-05-14","closing_date":null,"evidence_url":"https://www.linkedin.com/posts/pulse2news_degron-therapeutics-40-million-series-a-activity-7460693968167739393-FF6v","stages_label":"Series A","check_max_usd":null,"check_min_usd":null,"evidence_path":"/investors/funds/kinghall-ventures--hj35w8/evidence/2026-05-14--degron-therapeutics","closing_source":null,"evidence_quote":"CASSTAR, Kinghall Ventures, and GAGE Capital","funded_company":"Degron Therapeutics","has_intro_path":false,"verified_month":"May 2026","geography_label":"APAC","mandate_geography_label":null}],"stage":"series-a","answer":"As of September 24, 2026, the SeedForge Active Investor Index lists 27 Series A biotech investors with a publicly evidenced deal announced in the last 6 months, including ARCH Venture Partners, SV Angel, Oak HC/FT and Speciale Invest. Each row links to its announcement; investors without evidence in the last 180 days are removed at the weekly refresh.","counts":{"rows":27,"added_7d":0,"aged_out_7d":0,"excluded_week":5},"jsonld":{"url":"https://seedforge.com/investors/active/biotech/series-a","name":"Series A biotech investors active in 2026","@type":"Dataset","creator":{"url":"https://seedforge.com","name":"SeedForge","@type":"Organization"},"@context":"https://schema.org","mainEntity":{"@type":"ItemList","numberOfItems":27,"itemListElement":[{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#arch-venture-partners","name":"ARCH Venture Partners","@type":"Organization","description":"SeedForge records ARCH Venture Partners as a participant in Ramona's financing, announced 2026-09-22."},"@type":"ListItem","position":1},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#sv-angel","name":"SV Angel","@type":"Organization","description":"SeedForge records SV Angel as a participant in Huskeys's financing, announced 2026-09-08."},"@type":"ListItem","position":2},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#oak-hc-ft","name":"Oak HC/FT","@type":"Organization","description":"SeedForge records Oak HC/FT as a participant in Dash Bio's financing, announced 2026-08-10."},"@type":"ListItem","position":3},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#speciale-invest","name":"Speciale Invest","@type":"Organization","description":"SeedForge records Speciale Invest as a participant in Peptris's financing, announced 2026-08-05."},"@type":"ListItem","position":4},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#freestyle-capital","name":"Freestyle Capital","@type":"Organization","description":"SeedForge records Freestyle Capital as a participant in Dash Bio's financing, announced 2026-08-04. Evidence posted 2026-08-10."},"@type":"ListItem","position":5},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#swift-ventures","name":"Swift Ventures","@type":"Organization","description":"SeedForge records Swift Ventures as a participant in Dash Bio's financing, announced 2026-08-03. Evidence posted 2026-08-10."},"@type":"ListItem","position":6},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#gaorong-ventures","name":"Gaorong Ventures","@type":"Organization","description":"SeedForge records Gaorong Ventures as a participant in GenAns Biotech's financing, announced 2026-07-30."},"@type":"ListItem","position":7},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#mitsubishi-ufj-capital","name":"Mitsubishi UFJ Capital","@type":"Organization","description":"SeedForge records Mitsubishi UFJ Capital as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-29."},"@type":"ListItem","position":8},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#yuanbio-venture-capital","name":"YuanBio Venture Capital","@type":"Organization","description":"SeedForge records YuanBio Venture Capital as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-29."},"@type":"ListItem","position":9},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#vision-incubate","name":"Vision Incubate","@type":"Organization","description":"SeedForge records Vision Incubate as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29."},"@type":"ListItem","position":10},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#elikon-venture","name":"Elikon Venture","@type":"Organization","description":"SeedForge records Elikon Venture as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29."},"@type":"ListItem","position":11},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#utokyo-innovation-platform-co-ltd-utokyo-ipc","name":"UTokyo Innovation Platform Co., Ltd. (UTokyo IPC)","@type":"Organization","description":"SeedForge records UTokyo Innovation Platform Co., Ltd. (UTokyo IPC) as a participant in CORE Biomedicine, Inc.'s financing, announced 2026-07-28. Evidence posted 2026-07-29."},"@type":"ListItem","position":12},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#founders-fund","name":"Founders Fund","@type":"Organization","description":"SeedForge records Founders Fund as a participant in Shinkei Systems's financing, announced 2026-07-27."},"@type":"ListItem","position":13},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#korea-omega-investment-corp","name":"Korea Omega Investment Corp.","@type":"Organization","description":"SeedForge records Korea Omega Investment Corp. as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21."},"@type":"ListItem","position":14},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#sambrinvest","name":"Sambrinvest","@type":"Organization","description":"SeedForge records Sambrinvest as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21."},"@type":"ListItem","position":15},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#noshaq","name":"Noshaq","@type":"Organization","description":"SeedForge records Noshaq as a participant in Brenus Pharma's financing, announced 2026-07-20. Evidence posted 2026-07-21."},"@type":"ListItem","position":16},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#pangaea-ventures","name":"Pangaea Ventures","@type":"Organization","description":"SeedForge records Pangaea Ventures as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16."},"@type":"ListItem","position":17},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#shionogi-co-ltd","name":"Shionogi & Co., Ltd.","@type":"Organization","description":"SeedForge records Shionogi & Co., Ltd. as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16."},"@type":"ListItem","position":18},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#dg-daiwa-ventures","name":"DG Daiwa Ventures","@type":"Organization","description":"SeedForge records DG Daiwa Ventures as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16."},"@type":"ListItem","position":19},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#d4v","name":"D4V","@type":"Organization","description":"SeedForge records D4V as a participant in Dioseve's financing, announced 2026-06-17. Evidence posted 2026-06-16."},"@type":"ListItem","position":20},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#mirai-door","name":"Mirai Door","@type":"Organization","description":"SeedForge records Mirai Door as a participant in Dioseve's financing, announced 2026-06-16."},"@type":"ListItem","position":21},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#archetype-ventures","name":"Archetype Ventures","@type":"Organization","description":"SeedForge records Archetype Ventures as a participant in Dioseve's financing, announced 2026-06-16."},"@type":"ListItem","position":22},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#good-startup","name":"Good Startup","@type":"Organization","description":"SeedForge records Good Startup as a participant in StrainX Bioworks's financing, announced 2026-05-25."},"@type":"ListItem","position":23},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#fortune-capital","name":"Fortune Capital","@type":"Organization","description":"SeedForge records Fortune Capital as a participant in Degron Therapeutics's financing, announced 2026-05-14. Evidence posted 2026-05-21."},"@type":"ListItem","position":24},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#gage-capital","name":"GAGE Capital","@type":"Organization","description":"SeedForge records GAGE Capital as a participant in Degron Therapeutics's financing, announced 2026-05-14."},"@type":"ListItem","position":25},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#gtja-investment-group","name":"GTJA Investment Group","@type":"Organization","description":"SeedForge records GTJA Investment Group as a participant in Degron Therapeutics's financing, announced 2026-05-14."},"@type":"ListItem","position":26},{"item":{"url":"https://seedforge.com/investors/active/biotech/series-a#kinghall-ventures","name":"Kinghall Ventures","@type":"Organization","description":"SeedForge records Kinghall Ventures as a participant in Degron Therapeutics's financing, announced 2026-05-14."},"@type":"ListItem","position":27}]},"description":"27 investors with a publicly documented Series A biotech deal announced in the last 6 months. Every entry carries the announcement date and a link to its public evidence; inactive investors are removed at the weekly refresh.","dateModified":"2026-09-24","isAccessibleForFree":true},"sector":"biotech","status":"published","citation":"SeedForge Active Investor Index: Series A biotech investors active in 2026. Updated 2026-09-24. seedforge.com/investors/active/biotech/series-a","page_key":"biotech--series-a","changelog":{"added":[],"aged_out":0,"corrected":0},"h1_accent":"active in 2026.","seo_title":"Series A biotech investors active in 2026 with dated deals","check_chip":{"range":"$50K to $20M","disclosed":5},"updated_at":"2026-09-24","sector_label":"biotech","method_version":"v1.13","answer_question":"Which Series A biotech investors are active right now?","meta_description":"27 Series A biotech investors with a publicly evidenced deal announced in the last 6 months. Each row links to its announcement. Refreshed weekly by SeedForge.","teaser_intro_count":2}